448 related articles for article (PubMed ID: 11259234)
1. Procalcitonin in children admitted to hospital with community acquired pneumonia.
Moulin F; Raymond J; Lorrot M; Marc E; Coste J; Iniguez JL; Kalifa G; Bohuon C; Gendrel D
Arch Dis Child; 2001 Apr; 84(4):332-6. PubMed ID: 11259234
[TBL] [Abstract][Full Text] [Related]
2. Serum procalcitonin, C-reactive protein and interleukin-6 for distinguishing bacterial and viral pneumonia in children.
Toikka P; Irjala K; Juvén T; Virkki R; Mertsola J; Leinonen M; Ruuskanen O
Pediatr Infect Dis J; 2000 Jul; 19(7):598-602. PubMed ID: 10917215
[TBL] [Abstract][Full Text] [Related]
3. The utility of biomarkers in differentiating bacterial from non-bacterial lower respiratory tract infection in hospitalized children: difference of the diagnostic performance between acute pneumonia and bronchitis.
Hoshina T; Nanishi E; Kanno S; Nishio H; Kusuhara K; Hara T
J Infect Chemother; 2014 Oct; 20(10):616-20. PubMed ID: 25027057
[TBL] [Abstract][Full Text] [Related]
4. Non-specific host response markers in the differentiation between pneumococcal and viral pneumonia: what is the most accurate combination?
Korppi M
Pediatr Int; 2004 Oct; 46(5):545-50. PubMed ID: 15491381
[TBL] [Abstract][Full Text] [Related]
5. A three-step diagnosis of pediatric pneumonia at the emergency department using clinical predictors, C-reactive protein, and pneumococcal PCR.
Alcoba G; Keitel K; Maspoli V; Lacroix L; Manzano S; Gehri M; Tabin R; Gervaix A; Galetto-Lacour A
Eur J Pediatr; 2017 Jun; 176(6):815-824. PubMed ID: 28474099
[TBL] [Abstract][Full Text] [Related]
6. Procalcitonin is useful in identifying bacteraemia among children with pneumonia.
Nascimento-Carvalho CM; Cardoso MR; Barral A; Araújo-Neto CA; Guerin S; Saukkoriipi A; Paldanius M; Vainionpää R; Lebon P; Leinonen M; Ruuskanen O; Gendrel D
Scand J Infect Dis; 2010 Sep; 42(9):644-9. PubMed ID: 20438288
[TBL] [Abstract][Full Text] [Related]
7. Comparison of procalcitonin with C-reactive protein, interleukin 6 and interferon-alpha for differentiation of bacterial vs. viral infections.
Gendrel D; Raymond J; Coste J; Moulin F; Lorrot M; Guérin S; Ravilly S; Lefèvre H; Royer C; Lacombe C; Palmer P; Bohuon C
Pediatr Infect Dis J; 1999 Oct; 18(10):875-81. PubMed ID: 10530583
[TBL] [Abstract][Full Text] [Related]
8. Measurement of lipocalin-2 and syndecan-4 levels to differentiate bacterial from viral infection in children with community-acquired pneumonia.
Esposito S; Bianchini S; Gambino M; Madini B; Di Pietro G; Umbrello G; Presicce ML; Ruggiero L; Terranova L; Principi N
BMC Pulm Med; 2016 Jul; 16(1):103. PubMed ID: 27439403
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory response in mixed viral-bacterial community-acquired pneumonia.
Bello S; Mincholé E; Fandos S; Lasierra AB; Ruiz MA; Simon AL; Panadero C; Lapresta C; Menendez R; Torres A
BMC Pulm Med; 2014 Jul; 14():123. PubMed ID: 25073709
[TBL] [Abstract][Full Text] [Related]
10. Elevated inflammatory markers combined with positive pneumococcal urinary antigen are a good predictor of pneumococcal community-acquired pneumonia in children.
Galetto-Lacour A; Alcoba G; Posfay-Barbe KM; Cevey-Macherel M; Gehri M; Ochs MM; Brookes RH; Siegrist CA; Gervaix A
Pediatr Infect Dis J; 2013 Nov; 32(11):1175-9. PubMed ID: 23694836
[TBL] [Abstract][Full Text] [Related]
11. Procalcitonin levels are lower in intensive care unit patients with H1N1 influenza A virus pneumonia than in those with community-acquired bacterial pneumonia. A pilot study.
Piacentini E; Sánchez B; Arauzo V; Calbo E; Cuchi E; Nava JM
J Crit Care; 2011 Apr; 26(2):201-5. PubMed ID: 20813489
[TBL] [Abstract][Full Text] [Related]
12. Procalcitonin and C-reactive protein levels in community-acquired pneumonia: correlation with etiology and prognosis.
Hedlund J; Hansson LO
Infection; 2000; 28(2):68-73. PubMed ID: 10782390
[TBL] [Abstract][Full Text] [Related]
13. Comparison of diagnostic values of procalcitonin, C-reactive protein and blood neutrophil/lymphocyte ratio levels in predicting bacterial infection in hospitalized patients with acute exacerbations of COPD.
Tanrıverdi H; Örnek T; Erboy F; Altınsoy B; Uygur F; Atalay F; Tor MM
Wien Klin Wochenschr; 2015 Oct; 127(19-20):756-63. PubMed ID: 25586444
[TBL] [Abstract][Full Text] [Related]
14. Procalcitonin and C-reactive protein levels in HIV-positive subjects with tuberculosis and pneumonia.
Schleicher GK; Herbert V; Brink A; Martin S; Maraj R; Galpin JS; Feldman C
Eur Respir J; 2005 Apr; 25(4):688-92. PubMed ID: 15802344
[TBL] [Abstract][Full Text] [Related]
15. Serum procalcitonin concentrations in bacterial pneumonia in children: a negative result in primary healthcare settings.
Korppi M; Remes S; Heiskanen-Kosma T
Pediatr Pulmonol; 2003 Jan; 35(1):56-61. PubMed ID: 12461740
[TBL] [Abstract][Full Text] [Related]
16. Can we predict pneumococcal bacteremia in patients with severe community-acquired pneumonia?
Pereira JM; Teixeira-Pinto A; Basílio C; Sousa-Dias C; Mergulhão P; Paiva JA
J Crit Care; 2013 Dec; 28(6):970-4. PubMed ID: 24216331
[TBL] [Abstract][Full Text] [Related]
17. The diagnostic value of serum procalcitonin, IL-10 and C-reactive protein in community acquired pneumonia and tuberculosis.
Niu WY; Wan YG; Li MY; Wu ZX; Zhang LG; Wang JX
Eur Rev Med Pharmacol Sci; 2013 Dec; 17(24):3329-33. PubMed ID: 24379064
[TBL] [Abstract][Full Text] [Related]
18. Role of C-reactive protein and procalcitonin in differentiation of tuberculosis from bacterial community acquired pneumonia.
Kang YA; Kwon SY; Yoon HI; Lee JH; Lee CT
Korean J Intern Med; 2009 Dec; 24(4):337-42. PubMed ID: 19949732
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of serum procalcitonin in patients with community-acquired lobar pneumonia.
Lee JY; Hwang SJ; Shim JW; Jung HL; Park MS; Woo HY; Shim JY
Korean J Lab Med; 2010 Aug; 30(4):406-13. PubMed ID: 20805714
[TBL] [Abstract][Full Text] [Related]
20. Utility of serum procalcitonin and C-reactive protein in severity assessment of community-acquired pneumonia in children.
Agnello L; Bellia C; Di Gangi M; Lo Sasso B; Calvaruso L; Bivona G; Scazzone C; Dones P; Ciaccio M
Clin Biochem; 2016 Jan; 49(1-2):47-50. PubMed ID: 26386341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
